Skip to main content
Top

Cellular Oncology

Issue 2/2014

Content (6 Articles)

Genetic alterations in chondrosarcomas – keys to targeted therapies?

Andre M. Samuel, Jose Costa, Dieter M. Lindskog

Original Paper

Prognostic and predictive value of copy number alterations in invasive breast cancer as determined by multiplex ligation-dependent probe amplification

Sanaz Tabarestani, Sayyed Mohammad Hossein Ghaderian, Hamid Rezvani, Reza Mirfakhraie, Abdolali Ebrahimi, Hamid Attarian, Jahangir Rafat, Mojtaba Ghadyani, Hossein Afshin Alavi, Naser Kamalian, Afshin Rakhsha, Eznollah Azargashb

Original Paper

Combined arsenic trioxide-cisplatin treatment enhances apoptosis in oral squamous cell carcinoma cells

Toshiki Nakaoka, Akinobu Ota, Takayuki Ono, Sivasundaram Karnan, Hiroyuki Konishi, Akifumi Furuhashi, Yukinobu Ohmura, Yoichi Yamada, Yoshitaka Hosokawa, Yoshiaki Kazaoka

Original Paper

Analysis of gene copy number alterations by multiplex ligation-dependent probe amplification in columnar cell lesions of the breast

Anoek H. J. Verschuur-Maes, Cathy B. Moelans, Peter C. de Bruin, Paul J. van Diest

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine